MAPT and Alzheimer disease: All these processes alter the clearance of Aβ in brain tissue, stimulate the hyperphosphorylation of tau, promote astrocyte and microglia activation and the secretion of ROS, and, ultimately, exacerbate the signs and symptoms of AD [136].